TCL Archive Five-Year Course of Tamoxifen Remains Standard Treatment In HR+ Breast Cancer July 26, 2002
TCL Archive In Brief: Congress Sets NCI Rescission At $10.785 Million; Centers to Be Funded According To Priority Scores June 12, 1981
TCL Archive In Brief: Columbia’s Marks Reportedly Will Move To MSK; FDA Committee to Consider THC For Group C List May 23, 1980
TCL Archive More RFPs For Smoking/Health Projects Planned For Release As Subcontracts For Enviro Control March 14, 1975
